Immunoscore, based on the evaluation of CD3+ and CD8+ densities in the center of the tumor and its invasive margin, is currently considered as a potential prognostic factor, particularly in colorectal carcinomas. In the current study, we aimed to assess the prognostic value of immunoscore in colorectal cancer stage I to IV, through a survival study. It was a descriptive and retrospective study involving 104 cases of colorectal cancer.
View Article and Find Full Text PDFTunis Med
January 2019